GLP-1 Tirzepatide ReviewIndependent · S.J Partners LLC
Prices 9 verified of 64 Rubric v1.0-draft Prices verified 0 of 64 Evidence records 54 verified Corrections open log

Core & Trust

Conflicts of Interest Policy

Every relationship that could bias a page

Direct answer

Nobody on the editorial team holds a financial interest in a company covered here, accepts payment from a provider, or works for one. If that ever changes, the relationship is disclosed on every affected page and the person is removed from the affected coverage.

Answer last reviewed: not yet reviewed

Nobody on the editorial team holds a financial interest in a company covered here, accepts payment from a provider, or works for one. If that ever changes, the relationship is disclosed on every affected page and the person is removed from the affected coverage.

How this policy is applied
1Someone raises itA reader, a provider or an editor flags the issue.2It is assessed against the ledgerWe reopen the source and the capture date.3A decision is recordedCorrect, clarify, or explain why the original stands.4The change is published and datedOld figures stay visible in the log.
Show this figure as a table
Data table
StepStageWhat happens
1Someone raises itA reader, a provider or an editor flags the issue.
2It is assessed against the ledgerWe reopen the source and the capture date.
3A decision is recordedCorrect, clarify, or explain why the original stands.
4The change is published and datedOld figures stay visible in the log.
What this page commits us to
What this page commits us to
AreaCommitmentHow you can check it
Every figureCarries a source and a capture dateOpen the provenance stamp beside it
Every clinical claimTraced to a primary sourceFollow the citation, not our summary
Every scoreComputed from published inputsRead the raw inputs on the provider page
Every correctionDated and permanentRead the corrections log
Every reviewer credentialnot verifiedVerification in progress

What this policy covers

400 words · unwritten
  • Scope, in the reader's terms, not ours.

How we apply it

400 words · unwritten
  • Concrete process, with the responsible role named.

How to hold us to it

400 words · unwritten
  • Escalation route and expected response time.

Suspended reviewer credit — declared conflict of interest

Active disclosure

On 26 July 2026 we suspended this publication's medical reviewer credit. Both individuals we had recorded as reviewers are named on a competing seller's own published pages as its medical director and prescribers.

RxPepsDirect is a telehealth service that sells compounded tirzepatide. Its published comparison of compounded tirzepatide telehealth services — in which it ranks itself the cheapest option — carries the byline “Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC”, names Dr Snipes as its medical director under NPI 1821250077, and lists both as its prescribers.

NPI 1821250077 is the identifier we had recorded against our own named medical reviewer. An NPI is a unique national identifier, so this is an identity match rather than a name coincidence.

What that means

Our conflicts policy states that no clinician reviews a page about a company they work for, consult to, or hold an interest in. Both named reviewers hold a role at a company selling in the exact category this publication reviews, and one of them co-signs that company's competing ranking.

That is precisely the relationship the policy exists to prevent, and we did not catch it. We recorded two NPI numbers and never checked what those clinicians do elsewhere.

What we have done

  1. Suspended the reviewer credit sitewide. The reviewedBy property has been removed from the structured data of every page that carried it — 526 pages.
  2. Published the finding as COR-006 with the source and the date.
  3. Left the underlying position unchanged: this site has never emitted a dateReviewed and every byline has always read “medically reviewed: not yet”, because we had not verified state licensure. No page has ever published a medically-reviewed claim under either name.

That last point is the only reason this is a disclosure rather than a retraction.

What has not been established

We have not spoken to either clinician. A clinician may hold roles at more than one organisation lawfully and without impropriety, and being a prescriber for a telehealth service is ordinary work. What is not compatible with our policy is that person also carrying a reviewer credit here while doing so.

Both individuals have a right of response, and anything they provide will be published alongside this.

Why this is on the site rather than quietly fixed

A conflicts policy that has never caught anything is decoration. This one caught something that costs us the one credentialed byline we had, and publishing it is the only version of the policy that means anything.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Review. “Conflicts of Interest Policy.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/conflicts-of-interest/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Report an error
Comparing 0 of 4